Description: MKI-1 is a novel and potent inhibitor of MASTL (microtubule-associated serine/threonine kinase-like) with an IC50 of 9.9 μM, it exerts antitumor and radiosensitizer activities through PP2A activation in breast cancer.

纯度：≥98%

CAS：1190277-80-5